Pharmaceutical Business review

BioGaia Seals Agreement With Pharma Nord

BioGaia has entered into an agreement with Pharma Nord, which gives Pharma Nord exclusive rights to sell BioGaia’s Probiotic tablets and drops in Denmark.

Reportedly, BioGaia’s probiotic products will be sold under the BioGaia brand, marketed towards health professionals with distribution via pharmacies and health food stores. The launch is expected during the first half of 2010.

Peter Rothschild, president of BioGaia, said: ”Denmark is the only country in Scandinavia where we do not yet sell products and we now look forward to a successful launch built on our strong clinical data.”

BioGaia is a Swedish biotechnology company that develops and sells probiotic products and solutions that support people’s health.